Gtn Macarthys Laboratories (Glyceryl Trinitrate)

Gtn Macarthys Laboratories is indicated for several cardiovascular conditions where rapid vasodilation is required.

• Acute angina pectoris: rapid relief of chest pain episodes when they occur.
• Prophylaxis of angina: prevention of angina attacks during physical exertion or stress.
• Management of heart failure: adjunct therapy to improve symptoms such as dyspnea and fatigue.
• Use in controlled hypotensive episodes: administered under medical supervision to avoid excessive blood pressure drop.
• Emergency treatment of myocardial ischemia in a hospital setting: provides immediate vasodilation before definitive care.

The sublingual glyceryl trinitrate formulation can produce a range of pharmacologic effects, some of which are experienced by most patients while others are less frequent but clinically important.

Common

• Headache, often described as throbbing, due to cerebral vasodilation.
• Flushing or warmth in the face and neck.
• Dizziness or light‑headed feeling, especially when standing quickly.
• Hypotension manifested as a transient drop in blood pressure.
• Nausea or mild gastrointestinal discomfort.
• Palpitations or feeling of a racing heart.

Serious

• Severe hypotension with fainting (syncope).
• Rapid heart rate (tachycardia) or irregular rhythm.
• Chest pain that worsens despite treatment.
• Allergic reactions such as rash, itching, or swelling.
• Methemoglobinemia, a rare blood disorder.

When prescribing or using Gtn Macarthys Laboratories, clinicians and patients should observe several safety considerations to minimize adverse outcomes.

• Assess blood pressure before use; avoid if systolic pressure is below 90 mm Hg.
• Review history for severe anemia, increased intracranial pressure, or recent myocardial infarction.
• Use caution with phosphodiesterase‑5 inhibitors because combined use may cause profound hypotension.
• Advise patients to remain seated or lying down for several minutes after the sublingual dose.
• Store tablets in a tightly closed container, protected from moisture and light.

Glyceryl trinitrate may interact with other medications that influence vascular tone or nitric‑oxide pathways, requiring careful management.

Avoid

• Concurrent use of phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) due to risk of severe hypotension.
• Combined therapy with other nitrates or nitroglycerin preparations, which can cause additive vasodilation.
• Use with potent antihypertensive agents such as intravenous nitroprusside.

Use with caution

• Beta‑blockers: may mask tachycardia signs.
• Calcium channel blockers: may enhance hypotensive effect.
• Diuretics: can increase risk of volume depletion and low blood pressure.
• Alcohol: may potentiate vasodilatory response.
• Nitrates in topical form: concurrent use may increase overall nitrate load.